Get started
RocketTickers

La Jolla Pharmaceutical Company Announces Positive Results from

Long
RocketTickers  
NASDAQ:LJPC   None
Beyond Technical Analysis
1
1
beyondta
LJPC: La Jolla Pharmaceutical Company
2019-06-06 09:00:00
La Jolla Pharmaceutical Company Announces Positive Results from Pre-Specified Interim Analysis of Phase 2 Study of LJPC-401 in Patients with Hereditary Hemochromatosis - GlobeNewswire
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.